HEALTH● LOWSep 8 · Sep 8, 2026, 12:03 PM
AstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes
CNBC · global
The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca's peak annual sales forecast of more than $5 billion.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH32m agoNo Confirmed Case Of Diphtheria In Enugu — CommissionerChannels TVHEALTH47m agoWhat I learned from my stroke at 26BBC AfriqueHEALTH49m agoFG, Katsina Boosts Emergency Healthcare With 18 Ambulances, Upgraded General HospitalChannels TVHEALTH58m agoNicole Kidman's 59-year-old breakfast: matcha tea, puffed rice, red fruits, and almond milkClarín